Literature DB >> 2653335

Evolving concepts of oxytocin for induction of labor.

M Y Dawood1.   

Abstract

Based on findings of maternal and fetal circulating oxytocin levels during spontaneous labor and the available information on oxytocin secretion patterns, the dosage and mode of administration of oxytocin for induction of labor is discussed. It is recommended that intravenous infusion rates should not exceed 2 to 8 mU/min. Oxytocin administered in a pulsatile fashion beginning with 1 mU/min every 8 minutes with doubling the pulse dose every 24 minutes is equally as efficient as continuous infusion. Because both the peak levels and the total dose of oxytocin needed for induction are lower with pulsatile than continuous administration, the risk of adverse effects for the mother and the fetus is significantly reduced.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2653335     DOI: 10.1055/s-2007-999569

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  4 in total

1.  Historical cohort study of in utero exposure to uterotonic drugs and cognitive function in young adult life.

Authors:  H T Sørensen; K J Rothman; M W Gillman; F H Steffensen; P Fischer; S Sabroe
Journal:  BMJ       Date:  1999-02-13

2.  Oxytocin and the augmentation of labor : Human and medical perspectives.

Authors:  P Curtis
Journal:  Hum Nat       Date:  1993-12

3.  Maternal plasma levels of oxytocin during physiological childbirth - a systematic review with implications for uterine contractions and central actions of oxytocin.

Authors:  Kerstin Uvnäs-Moberg; Anette Ekström-Bergström; Marie Berg; Sarah Buckley; Zada Pajalic; Eleni Hadjigeorgiou; Alicja Kotłowska; Luise Lengler; Bogumila Kielbratowska; Fatima Leon-Larios; Claudia Meier Magistretti; Soo Downe; Bengt Lindström; Anna Dencker
Journal:  BMC Pregnancy Childbirth       Date:  2019-08-09       Impact factor: 3.007

Review 4.  Measuring Oxytocin and Vasopressin: Bioassays, Immunoassays and Random Numbers.

Authors:  G Leng; N Sabatier
Journal:  J Neuroendocrinol       Date:  2016-10       Impact factor: 3.627

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.